| Not obese (n = 39) | Obesea(n = 95) | p-value |
---|---|---|---|
Characteristics at 24 month post-diagnosis assessment |  |  |  |
CRP (mg/L), Mean (SD) | 1.2 (1.5) | 3.4 (3.7) | <.0001 |
SAA (mg/L), Mean (SD) | 4.2 (2.2) | 9.3 (17.9) | 0.008 |
Age at assessment, Mean (SD) | 53.2 (8.8) | 61.4 (10.3) | <.0001 |
Postmenopausal b - yes, n (%) | 18 (52.6) | 81 (91.0) | <.0001 |
Weight (kg) c , Mean (SD) | 58.9 (7.2) | 74.3 (12.1) | <.0001 |
BMI (kg/m 2 ), Mean (SD) | 21.9 (2.5) | 28.4 (4.3) | <.0001 |
Percentage of body fat, Mean (SD) | 29.7 (5.0) | 42.6 (4.7) | <.0001 |
Hip Circumference (cm), Mean (SD) | 96.0 (5.5) | 110 (9.3) | <.0001 |
Waist (cm), Mean (SD) | 74.2 (7.2) | 92.4 (11.2) | <.0001 |
Weight Change, n (%) | Â | Â | 0.06 |
Loss | 7 (18.0) | 5 (5.3) | Â |
No Changed | 22 (56.4) | 66 (69.5) | Â |
Gain | 10 (25.6) | 24 (25.3) | Â |
Physical Activity (MET hrs/week), n (%) | 44.7 (45.4) | 28.2 (24.9) | 0.04 |
Change in Physical Activity since baseline e (MET-hrs/week) | 6.7 (29.5) | -5.3 (31.6) | 0.04 |
History of Arthritis – yes, n (%) | 5 (12.8) | 50 (52.6) | <.0001 |
Hypertension f | 6 (15.4) | 31 (33.0) | 0.04 |
Past and current medication use - yes, n (%) | Â | Â | Â |
Tamoxifeng | 14 (35.9) | 41 (43.2) | 0.44 |
NSAID | 8 (20.5) | 40 (42.1) | 0.02 |
Chemotherapyh | 9 (23.1) | 19 (20.0) | 0.69 |